Kamalsons Pharma Private Limited
About Kamalsons Pharma Private Limited
Data last updated:
Kamalsons Pharma Private Limited is a private limited company based in Aurangabad, Maharashtra, India. It operates in the drug formulation and development segment of the pharmaceuticals sector. It was incorporated on 09 April 2023.
The company is registered with the Registrar of Companies (ROC), Mumbai, under CIN U21002MH2023PTC400366.
The company has an authorised share capital of ₹5 Lakh and a paid-up capital of ₹1 Lakh. It is led by directors Ujwala Babasaheb Jadhav and Vijaya Tejrao Sonwane.
Its last annual general meeting (AGM) was held on 30 September 2025, and its latest financial statements are for the year ended 31 March 2025. The registered office is at Plot No.8 Service Industries, Aurangabad, Maharashtra, India – 431001.
As per the financials filed for FY 2025, the company reported a revenue of ₹65.17 Lakh, reflecting significant growth compared to the previous year. For the same year it recorded a net profit of ₹4.34 Lakh (net margin 6.7%) and EBITDA of ₹6.05 Lakh (EBITDA margin 9.3%).
- EmailLocked
- TelephoneLocked
- WebsiteLocked
- Social MediaLocked
- Registered AddressPlot No.8 Service Industries, Aurangabad, Maharashtra, India – 431001
- IndustryPharma, Drug Formulation & Development
- Company details, directors and signatories
- Historical financials and ratios
- Shareholding pattern and group structure
- Charges with holder and property details
- Legal cases, compliance and MCA filings
- One PDF report, delivered after checkout
Business Activity of Kamalsons Pharma Private Limited
The main business activity of Kamalsons Pharma is human health and social work activities. In detail, this covers human health activities.
| Main Activity Group Code | Description of Main Activity | Business Activity Code | Description of Business Activity | Turnover Percentage |
|---|---|---|---|---|
| Q | Human health and social work activities | 86 | Human health activities | Locked |
Business activity turnover details
Turnover share and past changes in activity are in the company report.
- Turnover contribution
- Historical classifications
- Filing-level activity changes
Verified entity values are shown only after access is granted.
Financials of Kamalsons Pharma Private Limited FY 2025 filings available
Kamalsons Pharma Private Limited reported revenue of ₹65.17 Lakh (up 1019% YoY) for FY 2025.
Financial Statement Summary of Kamalsons Pharma Private Limited
| Metrics | FY 2024-25 | FY 2023-24 |
|---|---|---|
| Profit and Loss Statement | ||
| Revenue from Operations | •••• | •••• |
| Other Income | •••• | •••• |
| Total Revenue | •••• | •••• |
| Cost of Materials Consumed | •••• | •••• |
| Employee Benefit Expense | •••• | •••• |
| Finance Costs | •••• | •••• |
| Depreciation and Amortisation | •••• | •••• |
| Other Expenses | •••• | •••• |
| Total Expenses | •••• | •••• |
| EBITDA | ₹6.05 Lakh | •••• |
| Profit Before Tax | •••• | •••• |
| Tax Expense | •••• | •••• |
| Net Profit (PAT) | ₹4.34 Lakh | •••• |
| Balance Sheet | ||
| Share Capital | •••• | •••• |
| Reserves and Surplus | •••• | •••• |
| Net Worth (Total Equity) | •••• | •••• |
| Long-term Borrowings | •••• | •••• |
| Short-term Borrowings | •••• | •••• |
| Trade Payables | •••• | •••• |
| Total Liabilities | •••• | •••• |
| Fixed Assets | •••• | •••• |
| Investments | •••• | •••• |
| Inventories | •••• | •••• |
| Trade Receivables | •••• | •••• |
| Cash and Bank Balance | •••• | •••• |
| Total Assets | •••• | •••• |
Financial Ratios of Kamalsons Pharma Private Limited
| Metrics | FY 2024-25 | FY 2023-24 |
|---|---|---|
| Profitability | ||
| EBITDA Margin | 9.3% | •••• |
| Net Profit Margin | 6.7% | •••• |
| Return on Equity (ROE) | •••• | •••• |
| Return on Capital Employed (ROCE) | •••• | •••• |
| Return on Assets (ROA) | •••• | •••• |
| Liquidity and Debt | ||
| Current Ratio | •••• | •••• |
| Quick Ratio | •••• | •••• |
| Debt-to-Equity Ratio | •••• | •••• |
| Interest Coverage Ratio | •••• | •••• |
| Efficiency and Growth | ||
| Asset Turnover | •••• | •••• |
| Receivable Days | •••• | •••• |
| Payable Days | •••• | •••• |
| Inventory Days | •••• | •••• |
| Revenue Growth | •••• | •••• |
| Net Profit Growth | •••• | •••• |
Paid data: the figures shown as dots are available after purchase of the company report. Figures as filed with the MCA in Form AOC-4. The full year-wise statements and ratios of Kamalsons Pharma are in the company report.
Financial statements from FY 2024
Earlier years and trend charts are in the company report.
- Income statements
- Balance sheets
- Cash-flow statements
- Ratios and benchmarks
Verified entity values are shown only after access is granted.
Peer Comparison of Kamalsons Pharma Private Limited
Kamalsons Pharma Private Limited is compared with the companies closest to it by revenue in the Pharma industry (Formulations). Net profit, margin and employee counts of each company are in the company report.
| Company | Revenue | Net profit | Margin | Growth (1 yr) | Employees | Location |
|---|---|---|---|---|---|---|
| G and B Pharmaceuticals Private Limited | ₹65.84 Lakh (FY 2023) | •••• | •••• | 294.0% | •••• | Jagadhri, Haryana, India |
| Calsita Futuristic Private Limited | ₹65.57 Lakh (FY 2025) | •••• | •••• | 91.0% | •••• | Vadodara, Gujarat, India |
| Nunchi Pharma Private Limited | ₹65.56 Lakh (FY 2025) | •••• | •••• | 3.0% | •••• | Delhi, India |
| Kancare Pharmaceuticals Private Limited | ₹65.29 Lakh (FY 2023) | •••• | •••• | 1596.0% | •••• | Roorkee, Uttarakhand, India |
| Hindustan Pharmatech Private Limited | ₹65.21 Lakh (FY 2025) | •••• | •••• | -34.0% | •••• | Mumbai, Maharashtra, India |
| Kamalsons Pharma Private Limited this company | ₹65.17 Lakh (FY 2025) | •••• | •••• | 1019.0% | •••• | Aurangabad, Maharashtra, India |
| JH Herbo Shine Private Limited | ₹65.09 Lakh (FY 2025) | •••• | •••• | 204.0% | •••• | Lohardaga, Jharkhand, India |
| Lucis Pharmaceutical Private Limited | ₹64.98 Lakh (FY 2025) | •••• | •••• | -28.0% | •••• | Kolkata, West Bengal, India |
| Salubres Formulations Private Limited | ₹64.98 Lakh (FY 2025) | •••• | •••• | -56.0% | •••• | Hyderabad, Telangana, India |
| Varick Remedies Private Limited | ₹64.74 Lakh (FY 2018) | •••• | •••• | 43.0% | •••• | Secunderabad, Telangana, India |
| Beopt Biotech Private Limited | ₹64.64 Lakh (FY 2025) | •••• | •••• | -7.0% | •••• | Patna, Bihar, India |
Peers are the five companies nearest above and the five nearest below Kamalsons Pharma by revenue in the Pharma industry (Formulations), from the latest filed financials of each company. Net profit, margin and employee counts of each peer are in the company report.
Board of Directors of Kamalsons Pharma Private Limited
Kamalsons Pharma has 2 directors on record. No former directors are listed.
| Name | Designation | Appointment Date | Tenure | Status |
|---|---|---|---|---|
| Ujwala Babasaheb Jadhav | Director | 09 Apr 2023 | 3 Years 6 Months | Current |
| Vijaya Tejrao Sonwane | Director | 09 Apr 2023 | 3 Years 6 Months | Current |
Charges & Borrowings of Kamalsons Pharma Private Limited
Kamalsons Pharma Private Limited does not have any charges (loans) registered with the Registrar of Companies.
Employees and EPFO Compliance at Kamalsons Pharma Private Limited
Employment history and EPFO contributions of people linked to Kamalsons Pharma.
Employee and EPFO history
Monthly headcount, contribution history and filing status are in the company report.
- Monthly headcount
- PF contributions
- ECR filing status
- Establishment history
Verified entity values are shown only after access is granted.
Recent Activity on Kamalsons Pharma Private Limited
Kamalsons Pharma Private Limited has 2 board changes on record since 2023: 2 appointments. The latest: Ujwala Babasaheb Jadhav was appointed as Director on 09 Apr 2023.
Credit Ratings, Litigation & Regulatory Alerts for Kamalsons Pharma Private Limited
Credit ratings, litigation, and regulatory alerts
Credit ratings, court records and regulatory alerts are in the company report.
- Rating history
- Court and tribunal cases
- Regulatory alerts
- Director-linked violations
Verified entity values are shown only after access is granted.
MSME Payment Delays by Kamalsons Pharma Private Limited
MSME payment history
Amounts due to small suppliers, the reasons given and MSME-1 filings are in the company report.
- Outstanding amounts
- Delay periods and reasons
- MSME-1 filing history
- Vendor payment signals
Verified entity values are shown only after access is granted.
Subsidiaries & Group Companies of Kamalsons Pharma Private Limited
Corporate group structure
Parent, subsidiary, associate and joint venture records with holdings are in the company report.
- Parent company
- Subsidiaries and ownership
- Associates and joint ventures
- Entity investments
Verified entity values are shown only after access is granted.
GST Compliance of Kamalsons Pharma Private Limited
GST registrations and filing compliance
State-wise GST registrations, return filing status and HSN or SAC codes are in the company report.
- GSTIN registrations
- State-wise filing status
- HSN and SAC details
- Tax jurisdiction records
Verified entity values are shown only after access is granted.
MCA Filings & Documents of Kamalsons Pharma Private Limited
MCA filings and documents
Filed forms, annual returns, financial statements and charge filings with their dates are in the company report.
- Incorporation documents
- Annual returns and statements
- Charge filings
- Complete filing index
Verified entity values are shown only after access is granted.
Frequently Asked Questions about Kamalsons Pharma Private Limited
Kamalsons Pharma is an active private limited company based in Aurangabad, Maharashtra, India. The company works in drug formulation and development, within the pharma industry. It was incorporated on 09 April 2023 (3+ years old) and is registered under CIN U21002MH2023PTC400366.
Kamalsons Pharma reported revenue of ₹65.17 Lakh for FY 2025 (up 1019% YoY).
Kamalsons Pharma has 2 current directors:
- Ujwala Babasaheb Jadhav - Director
- Vijaya Tejrao Sonwane - Director
Kamalsons Pharma reported a net profit of ₹4.34 Lakh (net margin 6.7%) and EBITDA of ₹6.05 Lakh (EBITDA margin 9.3%) for FY 2025, as per its filed financial statements.
The CIN (Corporate Identification Number) of Kamalsons Pharma is U21002MH2023PTC400366. It is issued by the Ministry of Corporate Affairs under the Companies Act, 2013, and uniquely identifies the company in India.
Kamalsons Pharma was incorporated on 09 April 2023, making it 3+ years old. It is registered with the Registrar of Companies, Mumbai.
The peers of Kamalsons Pharma by revenue are G and B Pharmaceuticals Private Limited, Calsita Futuristic Private Limited, Nunchi Pharma Private Limited, Kancare Pharmaceuticals Private Limited, Hindustan Pharmatech Private Limited and 5 more, all in the Pharma industry (Formulations).
Ujwala Babasaheb Jadhav was appointed as Director on 09 Apr 2023. Vijaya Tejrao Sonwane was appointed as Director on 09 Apr 2023.
The registered office of Kamalsons Pharma is at Plot No.8 Service Industries, Aurangabad, Maharashtra, India – 431001.
Kamalsons Pharma has an authorised share capital of ₹5 Lakh and a paid-up capital of ₹1 Lakh.
Kamalsons Pharma operates in the pharma industry, in the drug formulation and development segment.